| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 50.575 | 41 | 1.122 | 8.999 | 6.335 | 1.820 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 50.575 | 41 | 5.139 | 12.269 | 6.349 | 1.820 |
| Total Expenses - EUR | 331 | 13 | 0 | 0 | 168 | 971 | 4.837 | 1.824 | 481 | 1.037 |
| Gross Profit/Loss - EUR | -331 | -13 | 0 | 0 | 50.407 | -930 | 302 | 10.446 | 5.868 | 784 |
| Net Profit/Loss - EUR | -331 | -13 | 0 | 0 | 49.901 | -931 | 290 | 10.181 | 5.070 | 578 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Microprobiotics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 53.707 | 53.146 | 52.247 | 51.288 | 50.295 | 3.187 | 3.996 | 5.868 | 10.913 | 12.728 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 481 | 0 | 0 | 84 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 2.059 | 5.168 | 10.114 | 11.848 |
| Cash | 53.707 | 53.146 | 52.247 | 51.288 | 50.295 | 3.187 | 1.456 | 700 | 799 | 796 |
| Shareholders Funds | -286 | -296 | -291 | -286 | 49.621 | -834 | -526 | 3.773 | 8.808 | 9.337 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 53.443 | 0 | 0 | 674 | 4.021 | 1.262 | 2.094 | 2.105 | 3.391 |
| Income in Advance | 53.993 | 53.443 | 52.538 | 51.574 | 0 | 0 | 3.260 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
4638
|
|||||||||
Comments - Microprobiotics S.r.l.